News from Fermion

Fermion extends its particle engineering capabilities

Fermion strengthens its particle engineering capabilities by investing in... (22 August 2016)

Fermion In the World’s Forefront of Safety

Fermion has attained level I, “In the World’s Forefront of Safety”, in the... (6 June 2016)

New regulatory files for hydroxychloroquine and sodium cromoglicate are now available

USDMF for Fermion’s hydroxychloroquine sulphate is now available for reference... (8 April 2016)

API manufacturing facility expansion, Hanko, Finland

2018 will mark the start of a new era in Fermion’s history as Fermion’s plant... (15 March 2016)

Successful ANVISA Inspection at Fermion's API manufacturing plant in Oulu, Finland

Fermion passed successfully ANVISA Inspection 2016 with three minor... (4 February 2016)


Manufacturer of Active Pharmaceutical Ingredients (API) for both generic and proprietary drug products since 1970.

Contract manufacturing services for APIs including oncology and highly potent compounds.

Meet us at:


CPhI North America, May 16-18, Philadelphia, USA